Skip to main content
. 2016 Oct 20;1(3):e000128. doi: 10.1136/bmjgh-2016-000128

Table 4.

Estimated number of users per 10 000 population with a chronic presentation of an NCD

Country Adults with hypertension Adults with diabetes Children with diabetes Adults with coronary disease Adults with cerebrovascular disease Adults with heart failure Adults with asthma Children with asthma People with asthma Adults with COPD
Bangladesh 954 610 26 145 47 16 351 290 641 269
Central African Republic 1398 410 18 242 17 10 391 373 764 205
Egypt 1021 456 19 207 22 31 463 294 757 295
Guinea 1361 445 19 188 14 7 373 392 765 207
Indonesia 1268 451 19 148 40 16 481 274 755 310
Iraq 856 673 29 207 25 31 390 374 764 201
Jordan 703 1062 45 207 29 31 439 319 758 226
Lebanon 1609 883 37 207 39 31 538 212 750 380
Liberia 1202 449 19 188 14 7 370 395 765 197
Philippines 830 391 17 148 51 16 543 324 867 260
Sierra Leone 1648 499 21 188 13 7 379 385 764 191
Syrian Arab Republic 990 752 32 207 30 31 428 332 760 229
Turkey 944 689 29 207 26 31 505 247 752 339
Ukraine 3484 843 36 285 68 42 389 140 529 513

Chronic NCD presentations include management of stable coronary disease, heart failure, hypertension, diabetes, COPD or asthma.

COPD, chronic obstructive pulmonary disease; NCD, non-communicable disease.